Clinical Trial Update: A Study of OPC-41061 in Subjects With Cardiac-induced Edema (Congestive Heart Failure) [Phase 3]

View source ↗

Summary

Phase 3 trial of OPC-41061 (tolvaptan) in subjects with cardiac-induced edema due to congestive heart failure has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• OPC-41061

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Cardiac Edema | Phase 3 | Status: COMPLETED | Results posted: 2014-01-30